Peer-influenced content. Sources you trust. No registration required. This is HCN.
Psych Congress Network
A Phase 2B study found that a 25mg dose of psilocybin, combined with psychotherapy, produced a significant drop in patients’ scores on the Montgomery Asberg Depression Rating Scale (MADRS) after 12 weeks. This finding underscores the potential of psilocybin-assisted therapy as a promising treatment for depression.
Psychiatry November 7th 2023
MDLinx
Despite the potential benefits of ketamine in treating a range of neurological and psychiatric disorders, the FDA has issued warnings about the potential risks associated with its use, emphasizing the need for careful prescription and clinical oversight.
Neurology November 7th 2023
Psychiatrist.com
The study suggests that approximately one heated yoga session per week was associated with significantly greater reduction in depression symptoms than a waitlist control. This finding indicates that heated yoga could be a viable non-medication-based treatment option for patients with moderate-to-severe depression.
Psychiatry November 1st 2023
This double-blind, placebo-controlled trial suggests that topiramate monotherapy may be an effective treatment for civilian PTSD. Despite the decrease in total CAPS score not being statistically significant, topiramate-treated patients exhibited significant reductions in reexperiencing symptoms.
The DEA and HHS have extended telehealth prescribing flexibilities through December 31, 2024. This critical service allows for continued prescribing of controlled medications via virtual practice, addressing a significant need for many patients with mental health conditions and substance use disorders.
Johns Hopkins Medicine
In her book, Kay Redfield Jamison explores how an active approach to adversity can help regenerate the mind. Drawing from sources as varied as Hippocrates, John Steinbeck, Sigmund Freud, and wartime diaries, she captures the chaos of war, the suffering it causes, and potential balms within reach.